Schweiger Dermatology Group Secures $20M Credit Facility from Triangle Capital Corporation

08:30 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Schweiger Dermatology Group (“SDG” or the “Company”) announced today that it has secured a $20 million debt facility from Triangle Capital Corporation (NYSE: TCAP) to help fund and support its growth. Under the terms of ...

Other Sources for this Article

Schweiger Dermatology Group
Melissa Schweiger Kleinman, 917-975-9561


More From BioPortfolio on "Schweiger Dermatology Group Secures $20M Credit Facility from Triangle Capital Corporation"

Quick Search


Relevant Topics

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...